MIA PaCa-2/RFP-luciferase stable cell line
MIAPaCa-2/RFP-Luciferase cells are derived from the human pancreas carcinoma MIA PaCa-2 cell line by stably integration of a constitutive RFP-Firefly luciferase stably expression construct. MIA PaCa-2 cells are widely used to study pancreatic cancer biology and to evaluate the effectiveness of new drugs and targeted therapies for treating pancreatic cancer. MIAPaCa-2/RFP-Luciferase cells stably stably express RFP and Firefly luciferase, can be used for in vitro assays and in vivo imaging.
Product Specifications
No additional specifications available.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400525-100 1x 100 µL
CD63 (MX-49.129.5), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472853-500 1x 500 µL
CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400669-500 1x 500 µL
P27 / KIP1 (SX53G8), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740370-500 1x 500 µL
CD117 (C117/370), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742818-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/2818R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details